These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 35444290)

  • 21. Delivery systems for enhancing oncolytic adenoviruses efficacy.
    Zhou YC; Zhang YN; Yang X; Wang SB; Hu PY
    Int J Pharm; 2020 Dec; 591():119971. PubMed ID: 33059014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of an E1A Gene Expression Cassette in an Oncolytic Adenovirus for Efficient Tumor Cell Killing Activity.
    Sakurai F; Nishimae F; Takayama K; Mizuguchi H
    Anticancer Res; 2021 Feb; 41(2):773-782. PubMed ID: 33517282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models.
    Man YKS; Aguirre-Hernandez C; Fernandez A; Martin-Duque P; González-Pastor R; Halldén G
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy.
    Kwon OJ; Kang E; Choi JW; Kim SW; Yun CO
    J Control Release; 2013 Aug; 169(3):257-65. PubMed ID: 23562633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager.
    de Sostoa J; Fajardo CA; Moreno R; Ramos MD; Farrera-Sal M; Alemany R
    J Immunother Cancer; 2019 Jan; 7(1):19. PubMed ID: 30683154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced anti-tumor efficacy and safety profile of tumor microenvironment-responsive oncolytic adenovirus nanocomplex by systemic administration.
    Choi JW; Dayananda K; Jung SJ; Lee SH; Kim D; Hu J; Bae YH; Yun CO
    Acta Biomater; 2015 Dec; 28():86-98. PubMed ID: 26365317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linearized oncolytic adenoviral plasmid DNA delivered by bioreducible polymers.
    Kim J; Kim PH; Nam HY; Lee JS; Yun CO; Kim SW
    J Control Release; 2012 Mar; 158(3):451-60. PubMed ID: 22207073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.
    Zhang L; Hedjran F; Larson C; Perez GL; Reid T
    Cancer Gene Ther; 2015 Jan; 22(1):17-22. PubMed ID: 25525035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic delivery of a novel liver-detargeted oncolytic adenovirus causes reduced liver toxicity but maintains the antitumor response in a breast cancer bone metastasis model.
    Zhang Z; Krimmel J; Zhang Z; Hu Z; Seth P
    Hum Gene Ther; 2011 Sep; 22(9):1137-42. PubMed ID: 21480822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations.
    Shirazi MMA; Saedi TA; Moghaddam ZS; Nemati M; Shiri R; Negahdari B; Goradel NH
    Pharmacol Ther; 2024 Apr; 256():108611. PubMed ID: 38387653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation.
    Yan D; Li G; Yuan Y; Li H; Cao H; Dai Y; Li Y; Zhang Z; Li F; Fang Y; Gao Q
    Cancer Gene Ther; 2024 Mar; 31(3):397-409. PubMed ID: 38102464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
    Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
    J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
    Gomez-Gutierrez JG; Nitz J; Sharma R; Wechman SL; Riedinger E; Martinez-Jaramillo E; Sam Zhou H; McMasters KM
    Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of oncolytic adenovirus for cancer treatment.
    Choi JW; Lee JS; Kim SW; Yun CO
    Adv Drug Deliv Rev; 2012 Jun; 64(8):720-9. PubMed ID: 22212901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy.
    Xie D; Tian Y; Hu D; Wang Y; Yang Y; Zhou B; Zhang R; Ren Z; Liu M; Xu J; Dong C; Zhao B; Yang L
    Signal Transduct Target Ther; 2023 Nov; 8(1):436. PubMed ID: 38016957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCL21/IL21-armed oncolytic adenovirus enhances antitumor activity against TERT-positive tumor cells.
    Li Y; Li YF; Si CZ; Zhu YH; Jin Y; Zhu TT; Liu MY; Liu GY
    Virus Res; 2016 Jul; 220():172-8. PubMed ID: 27157859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Human Pancreatic Cancers Following Local and Systemic Administration of Oncolytic Adenovirus Serotype 35.
    Ono R; Takayama K; Onishi R; Tokuoka S; Sakurai F; Mizuguchi H
    Anticancer Res; 2023 Feb; 43(2):537-546. PubMed ID: 36697099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.
    Nettelbeck DM
    J Mol Med (Berl); 2008 Apr; 86(4):363-77. PubMed ID: 18214411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
    Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
    Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dopamine antagonist, domperidone enhances the replication of an oncolytic adenovirus in human tumour cells.
    Nishimae F; Sakurai F; Ono R; Onishi R; Takayama K; Mizuguchi H
    J Gen Virol; 2022 Jun; 103(6):. PubMed ID: 35731650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.